SMPD3 and prostate carcinoma: Notably, Poggio et al. achieved the inhibition of exosomal secretion of PC3 prostate cancer cells by knockout of nSMase2 or Rab27a based on CRISPR‒Cas9, indicating a potential method of TDE inhibition53.